Back

Combination therapy in CV risk reduction: what are we waiting for in dyslipidaemia management?

1 September 2019 (13:10 - 13:27)
Organised by:
Congress Presentation Part of: Hypercholesterolemia management - What will be our options after tomorrow? Cardiovascular Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Philippe Gabriel Steg

Hospital Bichat-Claude Bernard, Paris (France)

3 More presentations in this session

Presentation thumbnail
To be or not to be…but at which goal?
Professor L. Tokgozoglu (Ankara, TR)
Slides Video
Presentation thumbnail
LDL-C reducing agents; what genetic tells us
Professor B. Ference (Cambridge, GB)
Slides Video
Presentation thumbnail
Getting to goals cost effectively, how can we make a difference?
Professor E. Stroes (Amsterdam, NL)
Slides Video

Access the full session

Session thumbnail
Hypercholesterolemia management - What will be our options after tomorrow?

The Event

Event poster

ESC Congress 2019

1 September 2019 13:10 CET
You may be interested in
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
thumbnail
ESC TV Today
Episode 7: Coronary spasm - Sex differences in heart failure
thumbnail
Congress Session
Optimal management of chronic coronary syndromes: putting the evidence into practice

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources